SYBX
Synlogic Inc
NASDAQ: SYBX · HEALTHCARE · BIOTECHNOLOGY
$0.63
-2.93% today
Updated 2026-04-30
Market cap
$7.49M
P/E ratio
—
P/S ratio
936.86x
EPS (TTM)
$-0.08
Dividend yield
—
52W range
$1 – $2
Volume
0.0M
Synlogic Inc (SYBX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-8.17%
ROA
-12.50%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2011 | — | $-2.88M | — | — | — |
| 2012 | — | $-3.66M | — | — | — |
| 2013 | — | $-6.44M | — | — | — |
| 2014 | — | $-15.83M | — | — | — |
| 2015 | $0.00 | $-24.98M | — | — | — |
| 2016 | $444000.00 | $-26.27M | 64.19% | -5,995.05% | -5,916.22% |
| 2017 | $2.44M | $-40.38M | 100.00% | -1,670.38% | -1,652.09% |
| 2018 | $2.52M | $-48.44M | 100.00% | -2,032.94% | -1,922.02% |
| 2019 | $2.22M | $-48.67M | 100.00% | -2,446.45% | -2,188.44% |
| 2020 | $545000.00 | $-56.54M | 100.00% | -11,094.68% | -10,373.76% |
| 2021 | $1.75M | $-58.12M | 100.00% | -3,464.37% | -3,313.45% |
| 2022 | $1.18M | $-66.15M | 100.00% | -5,713.47% | -5,605.68% |
| 2023 | $3.37M | $-57.28M | 100.00% | -1,636.34% | -1,699.26% |
| 2024 | $8000.00 | $-23.36M | 100.00% | -511,875.00% | -291,987.50% |
| 2025 | $0.00 | $-1.00M | — | — | — |